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ABSTRACT 
 
 Absolute quantitative PCR (qPCR) is a method that determines the 
concentration of DNA in a sample. Accurate, and reproducible quantification is 
required during forensic DNA processing since the results determine the volume 
of sample used during STR genotyping. If too little DNA is utilized allelic dropout 
can occur; if too much DNA is used an increase in the number of artifacts can 
result. In either case, sub-optimal DNA input-masses can lead to the 
misinterpretation of the evidentiary profile, by increasing the probability of drop in 
and/or drop out. 
 Generally, the qPCR method used during forensic DNA processing 
employs a set of standards, which are run with the questioned samples and used 
to generate a standard curve. These data are then used to establish a linear 
equation that is subsequently utilized to estimate the concentration of DNA in the 
unknown sample. However, standard curves have been shown to be prone to 
systematic and random error effects that impact the accuracy of the 
concentration estimate. 
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 This study examines two alternative methods to determine the DNA 
concentration for unknown samples, and compares them to the currently 
accepted protocol of running new dilutions/standards with every assay. The two 
alternative methods are: 1) using a validated standard curve, and 2) using linear 
regression of efficiency.  
 To examine the feasibility of using these two methods for forensic 
purposes, two samples were quantified, using qPCR, in quadruplicate over the 
course of three years and concentrations were calculated using all three 
methods. Effects that time, kit lot, and instrument calibration had on the 
concentrations was examined for both total human and Y-DNA. Specifically, 
methods were compared by examining variances in concentration over the three-
year period, and contrasting these results with the variances obtained within 
runs. The method which resulted in the smallest changes in concentration over 
time was regarded as the most stable. 
 Results show that of the three methods, the use of a validated curve 
resulted in less variation of DNA concentration between multiple runs. Further, 
the factor that had the largest impact on concentration variance was the 
calibration of the instrument. Based on these results, recommendations are 
provided. 
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Introduction 
 Quantification of human DNA is an integral part of the forensic DNA 
processing scheme. Quantification of DNA via UV-Vis spectroscopy, and slot blot 
(1) are not optimal methods for forensic purposes because they are either not 
human specific or are associated with a large level of uncertainty. Therefore, a 
more accurate (2) way to determine the initial human DNA concentration of 
samples is required. 
Quantitative PCR (qPCR) is a real-time PCR method used to quantify 
DNA in a sample. Accurate quantification allows the mass of DNA during STR 
typing to be controlled such that optimal genotyping results may be obtained (3). 
 There are generally two types of qPCR used in forensics: SYBR®-based 
qPCR (4), and TaqMan®-based qPCR (5). SYBR®-based qPCR employs a 
molecule that fluoresces when bound to double stranded DNA. Therefore, 
fluorescence increases with each PCR cycle as the DNA amplifies. TaqMan®-
based qPCR utilizes probes that bind to specific regions of the DNA. These 
probes are attached to both a fluorophore and a quencher molecule. When the 
Taq polymerase reaches the probe during extension, its exonuclease activity 
degrades the probe, thereby separating the quencher from the reporter. 
Therefore, as the cycle number increases, the signal intensity of the reporter also 
increases. While it is possible for SYBR® green assays to be engineered to be 
human specific (6), TaqMan® assays have the capability of being both human 
specific (7), and multiplexed (8). 	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One commonly employed TaqMan® based kit, available commercially, is 
the Quantifiler Duo® kit. It is an AmpliTaq®-based assay (9) that has the 
capability of quantifying the amount of total human and male DNA present in a 
sample. Quantifiler Duo® is a multiplex qPCR assay that uses probes with 
different reporter dyes which target human-specific and Y-specific regions. The 
human-specific probe targets the gene Ribonuclease P RNA Component H1 
(RPPH1), and the Y-specific probe targets the a region on the Y chromosome 
(SRY) (5). The kit also contains an internal PCR control (IPC), which is used to 
test for the presence of PCR inhibitors that could affect the amplification of the 
sample. The IPC is also used as a control to assess whether the 
assay/thermocycler is working as expected (5).	  
The Quantifiler Duo® kit has been previously validated for use in forensics 
(3,10,11). These studies concluded the assay was able to distinguish between 
total human and male DNA, and had the capability of detecting as little as 25 
pg/µl of male DNA in a mixture of male and female DNA. 	  
Accurate quantification of a sample is imperative during human 
identification testing. If the sample DNA is not quantified accurately, then an 
incorrect mass of DNA will be used during STR amplification. If too little DNA is 
used for STR analysis, allelic dropout may occur. If the rates of dropout are 
extreme, samples that contain a mixture of DNA from two contributors can 
incorrectly be considered single source. Further, the propensity to underestimate 
the number of contributors would increase as the actual number of contributors 
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increased.  Alternatively, if too much DNA is used the profile would exhibit 
indications of imbalanced amplification, detectable forward stutter, and/or high 
baseline noise levels (12,13). Currently, the method commonly used to determine 
DNA quantity in forensic laboratories was recommended by the manufacturer (5). 
The manufacturer’s recommended protocol (MRP) is based on the creation of a 
standard curve made up of 8 serial dilutions. The eight standards range from 
0.023 to 50 ng/µl of DNA. It is recommended that these standards be run in 
duplicate with every plate or run. A standard curve is then generated via an 
ordinary least squares regression and a relationship between the cycle threshold 
value and DNA concentration is established. The resulting equation is used to 
determine the concentration of the unknown samples run on that plate. Further, 
the standard samples can act as a control for the assay; if the standard curve 
does not result in the expected slope or y-intercept, then this may indicate an 
issue with the sample set up, instrument, or run. It may however, also be a 
symptom of incorrect serial dilution generation. 
While commonly employed and validated for forensic processing, using 
the linear parameters obtained from standards run on every plate may not be the 
optimal method to determine unknown DNA concentrations. For example, 
Grgicak et al (14) showed that 14 dilution sets which ranged in concentration 
from 50-0.023 ng/µl resulted in significant variation in the resultant slopes and Y-
intercepts. This research also suggested that the variation in these standard 
curves was not dependent on stock DNAs, but rather the serial dilutions 
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themselves (14). It was suggested that error propagated over the course of the 
serial dilutions can have substantial impacts (15,16,17,18), and can lead to 
concentrations that vary by a factor of up to 3. As a result, it was recommended 
that a single standard curve be generated and used throughout a substantial 
period of time. That is, the authors argued that the instrument, kit lots, and 
pipettes were more stable over time than the dilution series. (14)  
There are inherent benefits to using the method of a validated curve over 
the MRP. For one, it saves time and allows more samples to be run on each 
plate. Second, it was argued that it could also lead to less sample loss since 
intralaboratory reproducibility is expected to increase. (14) However, it should be 
noted that no stability study was conducted and no recommendations as to the 
length of time the validated curve should remain in use were given.	  
Directly utilizing the resultant PCR sample curve and fitting it to a kinetic-
based PCR model has also been shown to be a viable option for determining 
concentration and has been presented as an alternative to the MRP. By using a 
standard curve, the MRP assumes the amplification efficiency of each sample is 
equal; but this may not necessarily be the case (19). In fact, each sample has its 
own amplification efficiency and the efficiencies are known to vary from cycle to 
cycle. The types of models used to determine the amplification efficiency and the 
concentration of samples can be divided into two categories: The first are models 
that determine the efficiency from the slope of the log-linear phase of 
amplification (20) and the second type are non-linear regression models.  Boggy 
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et al (21) show that using a two-parameter mass action kinetic model of qPCR 
results in accurate quantification of samples without the need for a standard 
curve. This is based on a non-linear regression that examines the exponential 
phase of PCR and predicts the non-linear decline of amplification efficiency with 
every cycle. (21) 
Amplification efficiency may also be modeled using a sigmoidal function 
(22-26). One type of sigmoidal model, called linear regression of efficiency (LRE) 
by Rutledge et al. (27-30) uses a kinetic-based sigmoidal model to determine the 
concentration of individual samples without the use of an external calibrator. This 
method takes the raw fluorescence data and estimates the amplification 
efficiency, which is then used to determine the copy number of the sample. In 
combination with the theory, Rutledge et al. also developed a software program 
(30) that performs the calculations and provides the user with the DNA copy 
number, which can then be converted into the concentration. 
Given the recent advancements in qPCR analysis and the newly 
established methods to determine DNA concentrations, the goal of this research 
was to examine three different methods of generating concentrations from qPCR 
data for forensic purposes. These methods are the manufacturer’s recommended 
protocol (MRP), which utilizes a standard curve run on every plate, the validated 
curve (VC) method, which utilizes a single validated standard curve over the 
course of multiple runs, and linear regression of efficiency (LRE) modeling, which 
uses a modeling program to determine the concentration. For this analysis, two 
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DNA samples run in quadruplicate over the course of 13 runs over 3 years, using 
four kit lots, and between three preventative maintenance calibrations were 
analyzed using all three quantification methods. The variations in concentrations 
over time, kit and calibration number were examined, and the three methods 
performance and reproducibility were compared. 
 
Materials and Methods	  
Raw Data	  
 The qPCR data (i.e. Ct values) were collected from two samples (Sample 
1 and 2) which were run over 13 different assays, over a three-year period using 
the 7500 Sequence Detection System (Applied Biosystems, Foster City CA) and 
the Quantifiler® Duo quantification kit (Applied Biosystems, Foster City CA). 
Each sample was run in quadruplicate, resulting in a total of 52 runs per sample. 
During this period, the instrument was calibrated three times and four reagent 
kits lots were used. Table 1 shows the kit and calibration information for each 
run. 
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Table 1. Run Information for Samples 
Run Kit Calibration 
1 1 1 
2 1 1 
3 1 1 
4 1 1 
5 2 2 
6 3 2 
7 3 2 
8 3 3 
9 3 3 
10 3 3 
11 3 3 
12 4 3 
13 4 3 	  
 Since the Quantifiler® Duo kit tests for both total human and Y- DNA, both 
were analyzed during the course of this study. The concentrations for each assay 
and replicate were assessed using the three aforementioned methods; 1) MRP, 
2) VC, and 3) LRE.	  
 
IPC Stability Study	  
 The IPC cycle threshold from the standard curves, Sample 1 and Sample 
2, were compared to each other to identify any variation in the IPC Ct’s. The 
means and standard deviations of the Ct values were calculated for each set 
based on run date, calibration date, and the lot number of the kit. Plots exhibit Ct 
values for Samples 1 and 2 for each run, with error bars representing twice the 
standard deviation.	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Manufacturer’s Recommended Protocol (MRP)	  
  The manufacturer’s recommended protocol (5) (MRP) used a newly 
generated standard curve each time an assay was run. The standard curve was 
generated by comparing the cycle threshold to the logarithm of the concentration 
of a series of knowns varying in concentration from 50 to 0.023 ng/µl. All 
standards were made after an initial serial dilution from a 200 ng/µl stock 
solution. Each standard was run on the plate in duplicate. Ordinary least squares 
linear regression of the dilution series was performed to generate a standard 
curve that was ultimately used to determine the concentrations of the samples on 
the plate.	  
 The data used for analysis were exported from the 7500 sequence 
detection software (SDS), and contained the following information: the 
concentration of total Human DNA of Sample 1 and 2, Y-DNA of Sample 1 and 2, 
and the IPC threshold values of all samples. 
 
Validated Curve Protocol (VC)	  
  The validated curve was generated following Grgicak et al.’s (14) 
recommendation of generating validated standard curves. Specifically, nine 
standard dilution series were generated using multiple pipettes, and Quantifiler 
Duo® kit lots. The dilution series were run on three separate plates. All of the Ct 
values were plotted against the log of the DNA concentration and an ordinary 
least squares linear regression resulted in one representative slope and Y-
9 
 
intercept used as the parameters in the validated curve (VC). The same method 
was used for both total human and Y DNA.	  
 The human DNA concentration was therefore calculated using the 
following validated curve (VC):  
 𝐶! = −3.311 log 𝐷𝑁𝐴 + 28.561 (Equation 1) 
where Ct is the cycle threshold value and [DNA] is the concentration of DNA. 	  
 Similarly, the Y DNA concentration was calculated using the following 
validated curve: 𝐶! = −3.395log  [DNA]+ 29.505  (Equation 2) 
 where Ct is the cycle threshold and [DNA] is the initial DNA concentration of 
DNA in ng/µl.  
 These validated curves were used to calculate the DNA concentration for 
all 13 assays over the three year period.	  	  
Human Concentrations	  
 The mean concentration and the standard deviation were calculated 
based on run date, calibration date, and lot number for MRP and VC.  Scatter 
plots were also created. The information for each individual result was plotted 
along with the average for each run. Error bars represent two times the standard 
deviation. Dividing lines indicate the date of the last calibration and brackets 
show which kit lots were used. Scatter plots comparing calibration date to human 
concentration, and lot numbers to human concentration were also created.	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Y Concentrations	  
Scatter plots of Y-DNA concentrations of each sample were created in a 
similar fashion as the Human DNA concentrations described above. The 
concentration for each sample calculated by MRP and VC was plotted along with 
the average. Error bars represent twice the standard deviation about the means. 
Lines demarcate the dates of calibration. Similarly plots, which compare 
calibration date to Y concentration, and lot number to Y concentration were also 
created.	  	  
MRP and VC Comparisons	  
A student’s t-test was performed to compare the mean concentrations of 
each kit lot and calibration for MRP and VC. This was performed for both the total 
human and Y DNA concentrations of Sample 1 and Sample 2 using the 
comparing means function in AnalystSoft Inc., StatPlus:mac LE Version 2009. 
 An F-test, which compared the variances for each kit lot and calibration for 
MRP and VC, was performed with AnalystSoft Inc., StatPlus: mac LE Version 
2009. This was completed for both the total human and Y DNA concentrations of 
Sample 1 and 2.	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LRE Determination	  
 Raw data (∆Rn) for all runs were imported into the newest version of the 
LRE Analyzer (version 0.8.0) developed by Robert Rutledge (30). The copy 
number was calculated for each run in the software using the default settings. 
The Optical Calibration Factor (OCF) value was varied until the concentration 
was correct for as many of the expected values for the standard samples as 
possible.	  The Sample 1 data was then analyzed using the same calculated OCF 
value for each run. The Emax value was changed to 100%. The concentration was 
calculated from the copy number using the assumption that a single cell contains 
approximately 7pg of DNA. 
 This same procedure was performed for Sample 2 for the RPPH1 and 
SRY loci.	  	  
LRE Comparisons to VC	  
 To compare the LRE and VC data, the means and standard deviation 
were calculated based on run date, calibration date, and lot number. A scatter 
plot containing concentrations calculated by LRE and VC was created and 
compared run date to total human DNA concentration. The information for each 
sample was plotted along with the average for each run overlaying them. Error 
bars, representing two standard deviations, are also presented. Lines were 
placed on the graph demarcating the date of the last calibration. Brackets were 
added under the runs to indicate the kit lots used. Graphs were also generated 
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using the same method to compare both calibration date and lot number to 
human concentration.	  
 The same procedure and scatter plots were made for each Sample for 
both the Human and Y concentrations.	  
A t-test was performed to compare the mean concentrations from each kit 
lot and calibration for LRE and VC. This was performed for both total human and 
Y DNA. 
 An F-test to compare the variances of concentration obtained for each kit 
lot and calibration for LRE and VC was performed. This analysis was repeated 
for all samples and loci.	  
 
Radar Plots	  
 The overall average concentration of the human DNA for Sample 1 
calculated by VC was used as the reference point and all subsequent 
concentrations were compared to this by examining the sum of squares over the 
course of 13 runs. The sum of squares was then calculated for each calibration. 
These results were plotted along with the results of the overall sum of squares on 
a radar graph. 
 Another radar graph compared the MRP, VC, and LRE data obtained after 
the last calibration. The overall average concentration calculated by MRP was 
subtracted from the averages of each run during the third calibration cycle. The 
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differences were squared and the results were plotted on a radar plot. This was 
repeated for both VC and LRE methods. 	  
 The final radar plot was generated using the relative standard deviation 
(RSD) calculated (for the third calibration only) using the following equation:	  
 RSD = (!!)×  100%	  	  (Equation	  3)	  
 
where σ, is standard deviation, and x is average DNA concentration after the 
third calibration. The RSDs were calculated for MRP, VC and LRE, and plotted 
on the same radar plot for comparison. 
 
Male to Female Ratios 
 The concentrations calculated by MRP for both total human and Y DNA 
were used to calculate the amount of female DNA by subtracting the amount of Y 
DNA from the total human DNA. Once the concentration of female DNA was 
determined, the average for each run was calculated for both male and female 
DNA. The male and female DNA concentrations were plotted on a bar graph, and 
sorted by run number.  The error bars, representing twice the standard deviation, 
is also presented.  
The male to female ratio was calculated by taking the Y-DNA 
concentration and dividing it by the female DNA concentration. The male to 
female ratios were plotted on a bar graph, sorted by run number, and an error 
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bar representing twice the standard deviation is presented. These same 
calculations and graphs are presented for both the VC and LRE methods. 
 
Results and Discussion 
IPC Data	  
 An internal PCR control (IPC) is run with every sample and is expected to 
cross the fluorescence threshold at the same cycle each time. The IPC is an 
artificial template designed to be different from the target DNA, thus eliminating 
interaction between the control DNA and the probes designed for the total human 
and Y-DNA analysis (33). The fluorescence of the IPC is read using a unique 
reporter, thus allowing simultaneous analysis of the SRY, RPPH1, and IPC 
amplifications.  
 Since the samples used in this study originated from whole-frozen liquid 
sources, the IPC data for the 13 runs can also be used to assess long term 
stability of qPCR. Further IPC values for Sample 1, Sample 2 and the standard 
can be combined since the Ct values are expected to be the same, regardless of 
DNA source. 
Figure 1 shows the Ct value of the IPC for the 13 runs. The Ct values for 
Calibration 1 remain constant ranging from 29.31 to 29.43. When runs 4 and 5 
are compared, the Ct’s change from an average of 29.31 to 29.85, indicating a 
shift in average Ct’s of the IPC’s when calibration occurred. However, it should be 
noted that, the kit was also changed at this time. More telling is the change in 
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IPC values between runs 7 and 8. Here both runs were completed using kit 3 and 
the average IPC’s remain roughly the same. However, the variance within the run 
in run 8 is much larger than the variance in run 7 (P = 0.4), again suggesting the 
calibration, or corrective action taken during this calibration, significantly 
impacted the IPC signal across the plate.  
 
 
 
 
 
 
 
In order to examine the confounding effect, if any, that calibration and kit 
lot has on the Ct’s of the IPC, the data was sorted by calibration (Figure 2). The 
results indicate that a significant amount of variation occurred, not necessarily 
because of the kit, but because of the calibration. For example, Kit 3 was used 
after Calibration 2 and Calibration 3, and there is a larger variation in the data 
from Calibration 3 than Calibration 2. If the change in the Ct was solely due to 
changes in kit, then it is expected that the same average Ct would be observed in 
both Calibration 2 and 3. The average Ct’s observed were not the same, however 
a t-test showed that the difference was not significant (P = 0.07). The variances 
Figure 1. IPC Ct values over the course of 3 years with error bars representing 2SD of the mean. 
The black vertical lines after run 4 and run 7 indicate the point at which calibration took place. 
The brackets underneath the data points indicate kit lot. 
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of the Ct’s are significantly affected by instrument calibration as indicated by the 
significant changes in variance of the IPC’s Ct’s within Lot 3 and between 
Calibration 2 and 3. Although instrument calibration has a significant impact on 
the variance of the IPC, changes in kit lot may also impact these results as 
indicated by the drop in average Ct value from 29.60 to 29.05 for kit 3 and kit 4 
within Calibration 3. However, the change in average Ct for the IPC between kits 
cannot explicitly be taken as evidence of run variation between kits, as drop in 
the IPC Ct’s between kit 3 and 4 cannot be isolated from the expected small 
changes in IPC concentrations expected between lots. 
 
	  
Figure 2. Ct of IPC for each kit, sorted by calibration #, with error bars representing 2SD of the 
mean.  
 
Manufacturer’s Recommended Protocol (MRP) vs. Validated Curve	  
 According to the Applied Biosystems® Quantifiler Duo® manual (5), 
quantification of DNA should be based on the generation of a standard curve 
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calculated using a dilution series, run in duplicate on every assay/plate. This is 
the manufacturer’s recommended protocol or MRP. The data generated from the 
standards run on the plate are used to generate a linear equation, and the 
concentration of the unknown samples are determined using that equation. 
According to the MRP, the dilution series should be regenerated on a bi-weekly 
basis, thereby requiring new DNA standards be created and used a minimum of 
24 times per year. 
Previous studies have shown that it is difficult to generate dilution series 
such that the linear parameters remain constant over time (14). Further, it was 
shown that small changes in y-intercept between curves can have a large impact 
on the DNA concentration obtained for an unknown. Therefore, to further test the 
stability (or lack thereof) of the MRP, two samples were run over a three-year 
period using four different kit lots and three different instrument calibrations. 
In contrast to the MRP, a single validated curve may be utilized to 
determine DNA quantity. A validated curve (VC) is an equation for a standard 
curve that is used over a specified amount of time. Validated curves typically 
have a set number of runs for which they are valid, and that number is 
determined by the lab that is generating and using the curves. The VC is used 
instead of the MRP standards that are run with every assay, and is used the 
same way the MRP equation is applied. Here, the Ct value of each sample is 
substituted into the equation to solve for the initial DNA concentration.  	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y = m ∗ log(x)+ b	  	  (Equation	  4) 
 
where, y is the Ct value, m is the slope, x is the initial DNA concentration, and b 
is the y-intercept. In order to determine the concentration, Equation 4 is 
rearranged to,	  
x = 10(!!!! )	  	  (Equation	  5) 
 
The slope and y-intercept obtained during validation are substituted into Equation 
5 and used throughout the duration of the validated curve’s lifetime so the only 
information needed from a single assay is the Ct values of the samples 
containing unknown DNA concentrations. As a result of using a validated curve 
laboratories would be able to run 16 additional samples per assay/plate (14).	  
The method for generating validated curves, introduced in Grgicak et al. 
(14), was used in this study. This method attempts to introduce as much variation 
as possible during the creation of the standards which are used to generate the 
VC parameters. Therefore, nine dilution series were made using multiple pipettes 
and kit lots. To introduce further variation, the nine standard curves were 
subdivided into three groups, and run on three separate plates. The parameters 
for both human and Y- DNA were determined in this manner.	  
For this experiment, the validated curve used to determine total human 
DNA concentration was: 	   x = 10(!!!".!"#!!.!"" )	  	  (Equation	  6) 
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The validated curve used to determine Y DNA concentration was, 	  
 x = 10(!!!".!"!!!.!"# )   (Equation	  7)	  	  
 Figures 3 and 4 show a comparison of the total human DNA concentration 
for Samples 1 and 2 calculated by MRP and VC over the course of 13 runs.  
 Figure 3 shows that there is variation between runs when the total human 
DNA concentrations were calculated using MRP and VC. The overall mean of 
total human DNA concentration for Sample 1 when calculated by MRP was 4.33 
± 1.07 ng/µl, while the overall mean when calculated by VC was 3.91 ± 0.08 
ng/µl. A t-test was performed in order to compare the means of each method, 
and showed that there was a significant difference between the means (P = 
0.025).  The largest within run variance of Sample 1 for MRP was seen in run 5 
at 1.28. The largest within run variance for VC was observed in run 13 at 0.82.  In 
contrast, the overall variance (i.e. variance obtained from all runs) for MRP was 
1.15, while the overall variance for VC was 0.65. For the MRP method, the only 
run that had a within run variance higher than the overall variance was run 5. For 
the VC method, runs 9 and 13 had within run variances higher than the overall 
variance. The majority of runs for each method had within run variations smaller 
than the overall run variation suggesting reproducibility between runs is lower 
than the reproducibility within a run, which theoretically may be improved. 
Further, an F-test was performed to compare the overall variance of the two 
methods and it was found that there is a significant difference in the variance 
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between VC and MRP (P = 0.044). The variance is lower when calculated by VC, 
showing that VC is more reproducible than MRP.  
  
Figure 4 shows the concentrations of DNA for Sample 2 and shows the 
same trend observed in Sample 1. The overall mean of the total human DNA 
when calculated by MRP was 1.64 ± 0.40 ng/µl. When calculated by VC, the 
mean concentration was 1.44 ± 0.21 ng/µl. A t-test to compare the means of the 
two methods was performed and showed there was a significant difference 
between the means (P = .002). The concentrations calculated using VC had an 
overall variance of 0.04, which is smaller than the variance of the concentrations 
of Sample 2 when calculated by MRP (0.16).  The largest within run variance of 
Sample 2 for MRP was seen in run 3 at 0.19. The largest within run variance of 
Figure 3. Total human DNA concentration for Sample 1 calculated using MRP (        ) and VC (       ) 
over 3 years with error bars representing 2SD of the mean. The vertical black lines after runs 4 and 7 
indicate point at which calibration took place. The brackets under the data points show which kit lots 
were used. 
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Sample 2 for VC was also observed in run 3 at 0.22. For MRP, the only run that 
had a within run variance higher than the overall variance was run 3. For VC 
runs, 3 and 13 had a within run variance higher than the overall variance. As with 
Sample 1, the majority of within run variances are lower than the overall variance 
for both methods, suggesting the reproducibility between runs is lower than the 
reproducibility within a run. An F-test comparing the overall variances obtained 
from VC and MRP was performed and showed there was a significant difference 
in the calculated variances (P = 0.00001). 
 
 There were significant differences seen over time in variance between the 
MRP and VC for both Sample 1 and Sample 2. In both cases VC had the lower 
Figure 4. Total human DNA concentration for Sample 2 calculated using MRP (        ) and VC (       ) 
over 3 years with error bars representing 2SD of the mean. The vertical black lines after runs 4 and 7 
indicate point at which calibration took place. The brackets under the data points show which kit lots 
were used. 
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variance. This suggests that for Sample 1 and Sample 2 calculating total human 
DNA is more reproducible with the VC method then with the MRP. 
 Similarly, Figures 5 and 6 show a comparison of the Y DNA 
concentrations for Samples 1 and 2, calculated by both MRP and VC over the 
course of 13 runs. 
 Figure 5 shows that, like with total human DNA concentrations, Y DNA 
concentrations also vary over time when calculated using the MRP and VC 
methods. The overall mean of Y DNA concentration when calculated by MRP 
was 0.31 ± 0.09 ng/µl. The overall mean when calculated by VC was 0.29 ± 0.07 
ng/µl. A t-test was performed in order to compare the means of each method. 
The t-test showed that there was no significant difference between means of the 
two methods (P = 0.28). The largest within run variance of Sample 1 for MRP 
was seen in run 12 at 2.75x10-3. The largest within run variance for VC was seen 
in run 12 at 5.5x10-3. In contrast, the overall variance of all runs for MRP was 
8.4x10-3, while the overall variance for VC was 5.0x10-3. For MRP all of the within 
run variances were less than the overall variance, while for VC the only within run 
variance greater than the overall variance was seen in run 12. An F-test was 
performed to compare the overall variances of the two methods and it was found 
that there was no significant difference between them (P = 0.065).  
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Figure 6 shows the same trend of variance observed with Sample 1, 
Sample 2 and Sample 1Y. This plot indicates that over time the concentration of 
Y DNA in Sample 2 does not remain the same. The overall mean concentration 
of Y DNA when calculated by MRP was 1.71 ± 0.39 ng/µl. The overall mean 
when calculated by VC was 1.63 ± 0.34 ng/µl. A t-test was performed in order to 
compare the means of each method, and showed there is no significant 
difference between the means (P = 0.26). The largest within run variance of 
Sample 2 for MRP was observed in run 3 at 3.6x10-1. The largest within run 
variance for VC was also observed in run 3 at 3.4x10-1. The overall variance for 
MRP was 0.15, while the overall variance of VC was 0.11. The within run 
variance for each method was smaller than the overall variance with the 
exception of run 3, suggesting that reproducibility between runs is worse than it is 
Figure 5. Y DNA concentration for Sample 1 calculated using MRP  (        ) and VC(       ) over 3 
years with error bars representing 2SD of the mean. The vertical black lines after runs 4 and 7 
indicate point at which calibration took place. The brackets under the data points show which kit lots 
were used. 
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within the same run. An F-test to compare the overall variances was also 
performed for this data and suggested that there was no significant difference in 
variance between the two methods (P = 0.283). 
 
 
Even though there was only a significant difference in variance for Sample 
1Y, in both cases the variance was lower when using the VC method to calculate 
Y DNA. This corroborated the findings obtained when the total Human DNA 
concentrations were determined and suggests that using the VC method is more 
reproducible than using the MRP method over extended periods of time. 
The variation exhibited between runs can have a significant impact on 
downstream analysis. Since the concentration generated from qPCR is used to 
Figure 6. Y DNA concentration for Sample 2 calculated using MRP (      ) and VC (       ) over 3 years 
with error bars representing 2SD of the mean. The vertical black lines after runs 4 and 7 indicate 
point at which calibration took place. The brackets under the data points show which kit lots were 
used. 
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determine the volume of DNA extract used during STR amplification, it is 
important to assure the quantity obtained between runs is reproducible. 	  
Variables that could lead to this variation are the differences in DNA 
standard concentrations, component concentrations and/or efficiency of the 
polymerase between kit lots. To test this, four different kit lots were used during 
the course of this experiment. Kit lot 1 was used during runs 1-4, kit lot 2 was 
used to prepare run 5, kit lot 3 was used to prepare runs 6-11, and kit lot 4 was 
used to prepare the last two runs. 
Figures 7 and 8 show the total human DNA concentrations for Samples 1 
and 2 based on the kit lot. The 2SD spread of Sample 1, when calculated by 
MRP, for kits 1 through 4 was 1.41, 2.26, 1.81, and 1.26. The resultant Sample 1 
DNA concentrations when calculated via the VC resulted in 2SD spreads of 0.90, 
1.54, 1.39 and 1.60.  T-tests were performed in order to compare the means of 
kit lot concentrations. For MRP, P values < 0.05 were obtained when comparing 
kit lots 1 and 4, 2 and 4, and kit lots 3 and 4. For VC, P values < 0.05 were 
obtained between kits 1 and 3, and kits 1 and 4. It is difficult to determine if kit lot 
is the origin of these differences since the differences could have also been the 
result of modifications to the instrument system during calibration. If the runs 
using kit lot 3 during calibration 2 for MRP are removed and a t-test performed to 
compare the means of the remaining kit lot 3 and kit lot 4 samples, then there is 
still a significant difference in mean concentration between kit lots 3 and 4. This 
suggests that kit lot may also have an impact on the quantitation of DNA when 
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using MRP.  When comparing the variances between kit lots of Sample 1 via F-
tests for MRP, there was no significant difference in variance. When comparing 
the variances between kit lots of Sample 1 via F–tests for VC, P values <0.05 
were obtained between kits 1 and 3, and kits 1 and 4.  
 
 
 
 
 
 
 
 
 
 
 
The 2SD spread of Sample 2 for kits 1 through 4 was 0.32, 0.14, 0.53, and 
0.27, and of 0.18, 0.10, 0.33, and 0.34 for the MRP and VC methods 
respectively. When a t-test was performed on Sample 2 for MRP, P values < 0.05 
were obtained when comparing all kit lots.  T-tests were performed on the VC 
values for Sample 2 and P values < 0.05 were obtained between kits 1 and 4, 2 
and 3, and kits 2 and 4. When comparing the variances between kit lots of 
Sample 2 via F-tests for MRP, P values <0.05 were obtained between kits 1 and 
Figure 7. Total human DNA concentration for Sample 1 calculated by MRP (     ) 
and VC (     ) sorted by kit lot, with error bars representing 2SD of the mean. 
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2, 1 and 4, 2 and 3 and kits 3 and 4. When comparing the variances between kit 
lots of Sample 2 via F-tests for VC, P values < 0.05 were obtained between kits 1 
and 2, and kits 1 and 3. For Sample 2, it appears that VC yields more 
reproducible results because the means and variances are more similar. 
 
 
 
 
 
 
 
 
 
 
 
Figures 9 and 10 show the Y DNA concentrations for Samples 1 and 2 
based on the kit lot used. The 2SD spread of Sample 1 when calculated by MRP 
for kits 1 through 4 was 0.14, 0.006, .197 and .152, while Sample 1, when 
calculated by VC, had 2SD spreads of 0.06, 0.057, 0.10, and 0.119. T-tests 
comparing the means of each kit lot for Sample 1 Y when calculated using MRP 
resulted in P values < 0.05 between kits 1 and 4, 2 and 4, and kits 3 and 4. T-
tests comparing the means of each kit lot for Sample 1 Y when calculated using 
Figure 8. Total human DNA concentration for Sample 2 calculated by MRP (u ) 
and VC (     ) sorted by kit lot, with error bars representing 2SD of the mean. 
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VC resulted in P values < 0.05 between all kits except for between kits 2 and 3. 
When comparing the variances between kit lots of Sample 1Y via F-tests for 
MRP there was no significant difference seen. When comparing the variances 
between kit lots of Sample 1Y via F-tests for VC, P values <0.05 were obtained 
between kits 1 and 3, and kits 1 and 4. 
 
 
 
 
 
 
 
 
 
 
The 2SD spread of Sample 2 for kits 1 through 4 was 0.40, 0.49, 0.62, and 
0.30, and 0.18, 0.38, 0.43, and 0.32 for the MRP and VC methods respectively. 
T-tests comparing the means of each kit lot for Sample 2 Y, when calculated 
using MRP, resulted in P values <0.05 between kits 1 and 3, 1 and 4, 2 and 4, 
and kits 3 and 4. T-tests comparing the means of each kit lot for Sample 2 Y, 
when calculated using VC, resulted in P values <0.05 between kits 1 and 3, 1 
and 4, 2 and 4, and kits 3 and 4. When comparing the variances between kit lots 
Figure 9. Y DNA concentration for Sample 1 calculated by MRP    (     ) and             
VC (    ) sorted by kit lot, with error bars representing 2SD of the mean. 
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of Sample 2 via F-tests for MRP, P values <0.05 were obtained between kits 1 
and 4, and kits 3 and 4. When comparing the variances between kit lots of 
Sample 2 via F-tests for VC, P values <0.05 were obtained between kits 1 and 3, 
and kits 1 and 4.  
 
 
 
 
 
 
 
 
 
 
 
When calculating total human and Y DNA, variance is present between 
runs. This analysis shows that some of the variance is due to the kit lots. 
However the significant variance present between a majority of the kit may also 
be the result of normal instrument modification. As a result, the effects of 
calibrations were also examined. 
One confounding parameter, not considered in the previous analysis, was 
the effect of instrument calibration of the DNA quantification results. During the 
Figure 10. YDNA concentration for Sample 2 calculated by MRP (     ) and VC (    ) 
sorted by kit lot, with error bars representing 2SD of the mean. 
30 
 
yearly calibration that takes place during preventative maintenance, a number of 
tests and modifications are made to the 7500 sequence detection system. Some 
major modifications include block lamp and detector replacement; while 
moderate adjustment includes, but is not limited to, filter wheel calibration, the 
heated cover and/or ROI alignment and/or CCD alignment. Each of these are 
expected to impact the fluorescent signal obtained after each PCR cycle. If the 
source/detection path has changed significantly between calibrations, a change 
in calculated concentration may be the result. By using the MRP, the signal of the 
standards should be affected in the same way as the signal of the samples, 
thereby rendering differences between calibrations minimal. 
Figure 11 shows the total human DNA concentration calculated by MRP 
and VC for Sample 1, sorted by calibration. The mean total human DNA 
concentration when calculated by MRP was 4.59 ng/µl, 4.94 ng/µl, and 3.88 
ng/µl. The mean total human DNA concentration when calculated by VC was 
3.18 ng/µl, 3.91 ng/µl, and 4.39 ng/µl. T-tests were performed to compare the 
means of each calibration for MRP and VC to determine if the differences 
between them are significant. For MRP, P values <0.05 were obtained when 
comparing calibrations 1 and 3, and calibrations 2 and 3. For VC, P values <0.05 
were obtained when comparing calibrations 1 and 2, and calibrations 1 and 3. 
When comparing the variances between calibrations of Sample 1 via F-tests for 
MRP, no significant difference was observed. When comparing the variances 
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between calibrations of Sample 1 via F-tests for VC, P values <0.05 were 
obtained between calibrations 1 and 3. 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 shows the total human DNA calculated by MRP and VC for 
Sample 2 sorted by calibration. The mean concentration for each calibration 
when calculated by MRP was 1.96 ng/µl, 1.70 ng/µl, and 1.39 ng/µl. The mean 
concentration when calculated by VC was 1.31 ng/µl, 1.40 ng/µl, and 1.54 ng/µl. 
T-tests performed to compare the means of each calibration for MRP and VC to 
determine if there were significant differences between the two were performed. 
For MRP, P values <0.05 were obtained when comparing all calibrations. For VC, 
P values <0.05 were obtained when comparing calibrations 1 and 3, and 
calibrations 2 and 3. When comparing the variances between calibrations of 
Figure 11. Total human DNA concentration for Sample 1 calculated by MRP (     ) 
and VC (     ) sorted by calibration, with error bars representing 2SD of the mean. 
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Sample 2 via F-tests for MRP, no significant differences were found. When 
comparing the variance between calibrations of Sample 2 via F-tests for VC, P 
values <0.05 were obtained for calibrations 1 and 3, and calibrations 2 and 3. 
 
 
 
 
 
 
 
 
 
 
 
Figure 13 shows the Y DNA concentration calculated by MRP and VC for 
Sample 1 sorted by calibration. The mean Y DNA concentration when calculated 
by MRP was 0.336 ng/µl, 0.298 ng/µl, and 0.301 ng/µl. The mean Y DNA 
concentration when calculated by VC was 0.213 ng/µl, 0.290 ng/µl, 0.346 ng/µl. 
T-tests were performed to compare the means of each calibration for MRP and 
VC to determine if the differences are significant. The t-tests determined that 
there were no significant differences between calibrations for MRP. For VC, P 
values <0.05 were obtained when comparing calibrations 1 and 2, 1 and 3, and 
Figure 12. Total human DNA concentration for Sample 1 calculated by MRP (     ) 
and VC (     ) sorted by calibration, with error bars representing 2SD of the mean. 
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calibrations 2 and 3. When comparing the variances between calibrations of 
Sample 1 via F-tests for MRP, no significant differences were found. When 
comparing the variances between calibrations of Sample 1 via F-tests for VC, P 
values <0.05 were obtained when comparing calibrations 1 and 3. 
 
 
 
 
 
 
 
 
 
 
 
Figure 14 shows the Y DNA concentration calculated by MRP and VC for 
Sample 2 sorted by calibration. The mean Y DNA concentration when calculated 
by MRP was 2.01ng/µl, 1.73ngµl, and 1.50ng/µl. The mean Y DNA concentration 
when calculated by VC was 1.32ng/µl, 1.58ng/µl, and 1.85ng/µl. T-tests were 
performed to compare the means of each calibration for MRP and VC to 
determine if there was any significant difference. For MRP, P values <0.05 were 
obtained when comparing calibrations 1 and 2, 1 and 3, and calibrations 2 and 3. 
Figure 13. Y DNA concentration for Sample 1 calculated by MRP (    ) and VC (     ) 
sorted by calibration, with error bars representing 2SD of the mean. 
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For VC, P values <0.05 were obtained when comparing calibrations 1 and 2, 1 
and 3, and calibrations 2 and 3. When comparing the variances between 
calibrations of Sample 2 via F-tests for MRP no significant differences were 
found. When comparing the variances between calibrations of Sample 2 via F-
tests for VC, P values <0.05 were obtained between calibrations 1 and 2, and 
calibrations 1 and 3. 
 
 
 
 
 
 
 
 
 
 
 
Validated Curve Radar Plot for Calibrations Comparison  
Figure 15 is a radar plot, which is used to display multivariate data in the 
form of a two-dimensional chart of three or more quantitative variables. In Figure 
15, each number on the outside of the graph represents a single assay, and the 
y-values are the difference of squares between the mean concentration for a 
Figure 14. Total human DNA concentration for Sample 2 calculated by MRP (     ) 
and VC (     ) sorted by calibration, with error bars representing 2SD of the mean. 
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particular run date and the mean concentration over all runs. Specifically, the plot 
exhibits the value calculated using:	  
 y = (𝑥! − 𝑥!"")!	  	  (Equation	  8)	  
 
where 𝑥! is mean concentration for run n, and 𝑥!"" is the mean concentration of 
all 13 runs.	  
 Also displayed are the values calculated using:	  y = (𝑥! − 𝑥!"#!)!	  	  	  (Equation	  9)	  
 
where 𝑥! is mean concentration for run n and 𝑥!"#! is the mean concentration of 
all of the runs that took place during calibration n. 	  
 
 
 
 
 
 
 
 
 
 
Figure 15. Difference of Means Squared comparing overall average concentration for all calibrations 
( n  ) to individual calibrations (u) 
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The graph shows that there is a smaller sum of squares for the diamonds 
and solid line than the squares and dotted line, signifying that there is less 
concentration variation within a calibration than there is over multiple calibrations. 
The radar analysis suggests that if a new validated curve is generated each time 
the instrument is calibrated, a higher level of reproducibility between assays is 
expected. Figure 15 also demonstrates that if the same validated curve is used 
over the course of multiple calibrations, a larger difference in the spread of the 
concentrations is the expected result. 	  
 
Linear Regression Efficiency (LRE) vs. Validated Curve (VC)	  
 Linear Regression Efficiency (LRE) is a modeling method developed by 
Robert Rutledge (27-30) to determine sample concentration using qPCR and 
utilizes the ∆Rn information (i.e. fluorescence signal). This method allows for the 
calculation of sample concentration without the need to compare results to DNA 
standards. It has the potential to generate more accurate and reproducible 
concentrations because, unlike standard curve based methodologies, LRE 
modeling does not assume that the amplification efficiency of each sample is 
equivalent (35). 
LRE is a kinetic-based sigmoidal model that determines a sample’s 
concentration. The LRE Analyzer Software was developed (29-31) such that the 
fluorescent signal can be imported directly from the qPCR analysis system.  
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 This software uses the fluorescence readings produced by single PCR 
reactions, and generates a linear representation of amplification from those 
values. This is accomplished by plotting cycle efficiency (Ec) versus reaction 
fluorescence (Fc). This graph is known as the LRE plot, and the correlating 
equation for the linear curve is 	   E! = ∆E×F! + E!"#	  	  (Equation	  10)	  
 
where Ec is the amplification efficiency at cycle C (cycle efficiency), FC is the 
fluorescence reading at cycle C, Emax is the maximal amplification efficiency, ∆E 
is the rate of loss of cycle efficiency.	  
The amplification efficiency is empirically determined by evaluating the 
change in fluorescence with each PCR cycle as per the following equation	  
 E! = !!!!!!	  -­‐1	  (Equation	  11)	  
 
where Ec is cycle efficiency, FC is the fluorescence at cycle C and FC-1 is the 
fluorescence from cycle C-1. The linear equation is only used for the points that 
fall within the linear range, and are considered to be within the “LRE window” 
(27-31). The following equation, 
 F! = !!"#!!(!!"#!! !!)(!!"#!!)!	  	  (Equation	  12)	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is used to convert the fluorescence signal present in the LRE window into the 
target quantity in fluorescence units. Where F0 is target quantity expressed in 
fluorescence units, FC is the fluorescence at cycle C, Emax is the maximal 
amplification efficiency (determined by Equation 10), and Fmax is the maximum 
fluorescence signal.  	  
 The F0 value is then converted into absolute copy number using the 
optical calibration factor or OCF. Typically the OCF is determined by amplifying a 
known quantity of standard and dividing the resulting Fo value by the predicted 
quantity. 
 When utilizing the LRE method and corresponding software tool to 
analyze the DNA quantities of the samples for this work it was observed that the 
concentrations determined via LRE analysis were significantly different from the 
expected concentrations. As LRE was originally created for SYBR® Green 
assays (29), modifications to the software and corresponding OCF were required 
for data analysis of Taqman®-based assays. 	  
 The first modification included a change of Emax (maximum amplification 
efficiency) to 100% as opposed to the Emax calculated in Equation 10. Since 
Taqman® probes exhibit a decrease in fluorescence intensity over time, a lower 
Fmax value is detected. As a result, the Emax determined via Equation 11 may be 
underestimated. If Emax is underestimated then, as per Equation 12, the Fo and 
corresponding concentrations of the samples would be overestimated. 	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Figures 16 and 17 show a comparison of the total human DNA 
concentration for Samples 1 and 2 calculated by both LRE and VC over the 
course of 13 runs. The solid lines in between runs four and five and runs seven 
and eight represent points at which the calibrations took place. The brackets 
underneath the data points represent different kit lots used. 
As seen previously with the MRP and VC figures, Figure 16 shows that 
there is both within run and between run variation for LRE and VC. The overall 
mean of total human DNA concentration when calculated by LRE was 4.93 ± 
1.21 ng/µl compared to the 3.91 ± 0.81 ng/µl concentration calculated by VC. A t-
test was performed in order to compare the means of LRE and VC. The t-test 
showed there was a significant difference between the means of LRE and VC (P 
= 6.12x10-6). The largest within run variance of Sample 1 for LRE was seen in 
run 8 at 3.49. The overall variance of all runs for LRE was 1.46. Also the within 
run variance for the LRE method was larger and is particularly noticeable in runs 
3 and 8.  
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Figure 17 shows the quantification results for Sample 2. The overall mean 
of total human DNA concentration when calculated via LRE was 2.15 ± 0.38 
ng/µl compared to the 1.44 ± 0.21 ng/µl concentration calculated by VC. A t-test 
was performed in order to compare the means of LRE and VC. It showed that 
there was a significant difference between the means of LRE and VC (P = 0). 
The largest within run variance of Sample 2 for LRE was seen in run 3 at 0.551. 
The overall variance of all runs for LRE was 0.142. Unlike with Sample 1, for 
Sample 2 all of the within run variances are smaller than the overall variance. An 
F-test to compare the variance of LRE and VC was performed and showed that 
there was a significant difference in the variance (P = 3.8 x 10-5). The variance is 
lower for Sample 2 when calculated by VC, showing that VC is again more 
reproducible then the LRE quantification method. 
Figure 16. Total human DNA concentration for Sample 1 calculated using LRE  (        ) and VC (       ) 
over 3 years with error bars representing 2SD of the mean. The vertical black lines after runs 4 and 7 
indicate point at which calibration took place. The brackets under the data points show which kit lots 
were used. 
41 
 
 
 
Figure 18 shows the concentration of Y DNA in Sample 1 calculated by 
LRE and VC. The overall mean of Y DNA concentration when calculated by LRE 
was 0.16 ± 0.04 ng/µl, compared to the 0.29 ± 0.07 ng/µl concentration 
calculated by VC. A t-test was performed to compare the means of LRE and VC. 
The test showed that there was a significant difference between the means of 
LRE and VC (P = 0). The largest within run variance of Sample 1 for LRE was 
seen in run 12 at 1.5x10-3. The overall variance of all runs for LRE was 1.5x10-3, 
compared to the overall variance of all runs for VC, which was 5.0x10-3. For 
Sample 1Y all of the within run variances are equal to or lower than the overall 
variance. An F-test was performed to compare the variance of LRE and VC and it 
was found that there is a significant difference in the variance (P = 2.9X10-5).  
This is the first case where VC did not have the lowest variance. 
Figure 17. Total human DNA concentration for Sample 2 calculated using LRE (     ) and VC (       ) 
over 3 years with error bars representing 2SD of the mean. The vertical black lines after runs 4 and 7 
indicate point at which calibration took place. The brackets under the data points show which kit lots 
were used. 
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Figure 19 shows the concentration of Y DNA in Sample 2 calculated by 
LRE and VC. The overall mean of Y DNA concentration when calculated by LRE 
was 1.42 ± 0.31 ng/µl, compared to the 1.63 ± 0.34 ng/µl concentration 
calculated by VC. A t-test was performed in order to compare the means of LRE 
and VC. The test showed that there was a significant difference between the 
means of LRE and VC  (P = 1.6 x 10-3). The largest within run variance of 
Sample 2 for LRE was seen in run 8 at 0.114. The overall variance of all runs for 
LRE was 0.097, compared to the overall variance of all runs for VC, which was 
0.11. For Sample 2Y all but one of the within run variances was lower than the 
overall variance. An F-test was performed to compare the variance of LRE and 
VC and it was found that there is no significant difference in the variance (P = 
0.30). 
Figure 18. Y DNA concentration for Sample 1 calculated using LRE  (      ) and VC (       ) over 3 
years with error bars representing 2SD of the mean. The vertical black lines after runs 4 and 7 
indicate point at which calibration took place. The brackets under the data points show which kit lots 
were used. 
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When calculating Y DNA for Sample 1 and Sample 2 the variance was 
smaller than the variance for VC, which shows that LRE has potential. However, 
there were some instances where the data input into the LRE program did not 
yield a result, and when calculating total human DNA VC still shows a lower 
variance. This suggests that VC is the more reliable method. 
 Figures 20 and 21 show the total human DNA concentrations for Samples 
1 and 2 based on the kit lot used. The 2SD spread of Sample 1 when calculated 
by LRE for kits 1 through 4 was 1.20, 2.54, 2.08, and 2.23, while Sample 1 when 
calculated by VC had 2SD spreads of 0.90, 1.54, 1.39, and 1.60.  
 
 
 
Figure 19. Y DNA concentration for Sample 2 calculated using LRE  (      ) and VC (       ) over 3 
years with error bars representing 2SD of the mean. The vertical black lines after runs 4 and 7 
indicate point at which calibration took place. The brackets under the data points show which kit lots 
were used. 
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The 2SD spread of Sample 2 when calculated by LRE for kits 1 through 4 
was 0.25, 0.60, 0.58, and 0.56, while Sample 2 when calculated by VC had 2SD 
spreads of 0.18, 0.10, 0.33, and 0.34. 
 
 
 
 
 
 
 
 
 
 
Figure 20. Total human DNA concentration for Sample 1 calculated by LRE  (     ) 
and VC (     ) sorted by kit lot, with error bars representing 2SD of the mean. 
Figure 21. Total human DNA concentration for Sample 2 calculated by LRE (       ) 
and VC (     ) sorted by kit lot, with error bars representing 2SD of the mean. 
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Figures 22 and 23 show the Y DNA concentrations for Samples 1 and 2 
based on the kit lot used. The 2SD spread of Sample 1 when calculated by LRE 
for kits 1 through 4 was 0.04, 0.04, 0.05, and 0.08, while Sample 1 when 
calculated by VC has 2SD spreads of .06, .06, 0.01, and 0.12. 
 
 
 
 
 
 
 
 
 
 
  
The 2SD spread of Sample 2 when calculated by LRE for kits 1 through 4 
was 0.33, 0.47, 0.42, and 0.45, The Y-DNA concentrations for Sample 2 when 
calculated by VC had 2SD spreads of 0.18, 0.38, 0.43, and 0.32.  
Figure 22. Y DNA concentration for Sample 1 calculated by LRE (     ) and VC (    ) 
sorted by kit lot, with error bars representing 2SD of the mean. 
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Figure 24 shows the total human DNA calculated by LRE and VC for 
Sample 1 sorted by calibration. The mean total human DNA concentration when 
calculated by LRE was 3.82 ± 0.75 ng/µl, 5.32 ± 1.18 ng/µl, and 5.40 ± 1.03 
ng/µl. The mean total human DNA concentration when calculated by VC was 
3.18 ± 0.46 ng/µl, 3.91 ± 0.67 ng/µl, and 4.39 ± 0.70 ng/µl. 
 
 
 
 
 
 
Figure 23. Y DNA concentration for Sample 2 calculated by LRE (     ) and VC (    ) 
sorted by kit lot, with error bars representing 2SD of the mean. 
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Figure 25 shows the total human DNA calculated by LRE and VC for 
Sample 2 sorted by calibration. The mean total human DNA concentration when 
calculated by LRE was 1.77 ± 0.23 ng/µl, 2.25 ± 0.23 ng/µl, and 2.33 ± 0.33 
ng/µl. The mean total human DNA concentration when calculated by VC was 
1.31 ± 025 ng/µl, 1.40 ± 0.07 ng/µl, and 1.55 ± 0.17 ng/µl.  
Figure 24. Total human DNA concentration for Sample 1 calculated by LRE  (     ) and 
VC (     ) sorted by calibration, with error bars representing 2SD of the mean. 
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Figure 26 shows the Y DNA calculated by LRE and VC for Sample 1 
sorted by calibration. The mean Y DNA concentration when calculated by LRE 
was 0.12 ± 0.02 ng/µl, 0.17 ± 0.02 ng/µl, and 0.19 ± 0.04 ng/µl. The mean Y DNA 
concentration when calculated by VC was 0.21 ± 0.03 ng/µl, 0.29 ± 0.04 ng/µl, 
and 0.35 ± 0.10ng/µl.  
 
Figure 25. Total human DNA concentration for Sample 2 calculated by LRE  (     ) 
and VC (     ) sorted by calibration, with error bars representing 2SD of the mean. 
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Figure 27 shows the Y DNA concentration calculated by LRE and VC for 
Sample 2 sorted by calibration. The mean Y DNA concentration when calculated 
by LRE was 1.10 ± 0.22 ng/µl, 1.50 ± 0.18 ng/µl, and 1.57 ± 0.27 ng/µl. The 
mean Y DNA concentration when calculated by LRE was 1.32 ± 0.33 ng/µl, 1.58 
± 0.15 ng/µl, and 1.85 ± 0.22 ng/µl.  
 
Figure 26. Y DNA concentration for Sample 1 calculated by LRE (    ) and VC   (     ) sorted 
by calibration, with error bars representing 2SD of the mean. 
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One issue that did occur with the LRE software, was that not every sample 
input into the software gave a result. The software was not able to determine the 
amplification efficiency, which led to the samples being unable to be modeled 
and no concentrations were able to be determined. For total human DNA of 
Sample 1, 12% of the samples failed, for total human DNA of Sample 2, 13% of 
the samples failed, for Y DNA of Sample 1, 9% of the samples failed and for Y 
DNA of Sample 2, 6% of the samples failed. The samples that did not work 
showed extreme plateau drift or profile arching and it is hypothesized that this 
could have been caused by the TaqMan® probe chemistry. This indicates that 
modifications to the Emax value is not sufficient and LRE based qPCR analysis 
may not be a suitable analysis for TaqMan® based chemistries. 
Figure 27. Y DNA concentration for Sample 2 calculated by LRE (     ) and VC(     ) sorted by 
calibration, with error bars representing 2SD of the mean. 
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 One issue with LRE modeling is that it assumes a symmetric relationship 
between the baseline and plateau phase of amplification. Speiss et al (23) have 
proposed a change to the sigmoidal model that adds another parameter to allow 
for asymmetry between the two stages. This could potentially lower the 
percentage of failed samples analysis as it may account for the plateau drift and 
profile arching.  
Therefore, in order for this methodology to be an alternative to VC, further 
changes need to be implemented to lower the variances and to improve the 
accuracy of the quantification result. 
 
Radar Graphs	  
 Figure 28 shows a radar plot comparing the differences between the mean 
concentration and the actual concentrations during calibration 3 of Sample 1 for 
MRP, VC, and LRE.  
Calibration 3 was used because it is the calibration that contained the 
most runs. The area under the lines of the graph representing MRP, VC, and 
LRE, were calculated to determine which one had the most desirable (smaller) 
area. The area for VC (4.3 x 10-3) was lower than the area for MRP (5.3 x 10-1) 
and LRE (3.3 x 10-2); meaning that within the third calibration, the concentrations 
calculated by VC are more reproducible than those calculated by MRP or LRE.  
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Figure 29 shows the coefficient of variation (CV) during calibration 3 for 
the concentrations calculated by MRP, VC, and LRE. The coefficient of variation 
is largest for LRE, which suggests that LRE has the largest spread of data points 
from the mean and is consistent with the larger standard deviations seen in 
Figures 16, 17, 18 and 19 for the LRE method. The areas under the lines of the 
graph for each method were calculated for MRP, VC, and LRE to determine 
which method had the smallest area. The area calculations showed that VC had 
Figure 28. Difference of Mean Squared comparing MRP (     ), VC (       ) and LRE (     ) during 
Calibration 3.	  
8 
9 
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the smallest area (616) compared to MRP (699) and LRE (939), again 
suggesting that within a calibration the VC method results in greater 
quantification reproducibility. 
 
 
Male to Female ratio 
 Mixtures are commonly encountered in forensics. The Quantifiler Duo® 
chemistry is designed such that both total human and Y-DNA can be detected 
and quantified. Since both are known, the amount of female DNA is discernable.  
 Figure 30 shows the male DNA concentrations and the female DNA 
concentrations in Sample 1 calculated by MRP.  
Figure 29. Relative Standard Deviation for MRP (       ), VC (       ) and LRE  (      ) during the 
six runs of Calibration 3. 
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 Figure 31 shows the corresponding male: female ratios for Sample 1 
calculated by MRP. The figure shows that the ratio is not consistent over time. 
This can be an issue because determining the wrong ratio has an effect on the 
data analysis portion of STR. 
 
 
 
Figure 31. Male : Female mixture ratio determined by MRP with error bars representing 2SD of the 
mean 
Figure 30. Male (Dark Grey) and Female (Light Grey) DNA concentrations calculated by MRP with 
error bars representing 2SD 
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Figure 32 shows the male and female DNA concentrations in Sample 1 
determined by VC. Both male and female DNA concentrations calculated via VC 
appear to be more consistent over time then those calculated by the MRP 
method.  Figure 33 shows the male to female ratio calculated by VC, which is 
also more consistent over time than it was for MRP. 
 
 
 
 
 
Figure 32. Male (Dark Grey) and Female (Light Grey) DNA concentrations calculated by VC with 
error bars representing 2 SD of the mean 
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Figure 34 shows the male and female DNA concentrations in Sample 1 
determined by LRE. Figure 35 shows the male to female ratio calculated by LRE. 
LRE lacks the consistency of VC and MRP. 
This suggests that the accuracy of the DNA concentrations for both the 
total human and Y DNA play a pertinent role in determining the male: female 
ratio and the female quantity of DNA. If the ratio is calculated incorrectly it may 
lead to the incorrect decision on whether to test the sample using Y-STR’s. 
Therefore consistency in the absolute quantification of the human and male DNA 
is of importance.  
 
Figure 33. Male : Female mixture ratio determined by VC with error bars representing 2SD of the 
mean 
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In summary, the male: female ratios calculated by MRP ranged from 1:9 to 
1:22, the ratios calculated by VC ranged from 1:10 to 1:14, and the ratios 
calculated by LRE ranged from 1:24 to 1:34. The ratios calculated by LRE are 
higher than the other two methods because the concentrations determined by 
Figure 34. Male (Dark Grey) and Female (Light Grey) DNA concentrations calculated by LRE with 
error bars representing 2SD of the mean 
Figure 35.  Male : Female mixture ratio determined by LRE with error bars representing 2SD of the 
mean	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LRE for the Y-DNA of Sample 1 are much lower than the values calculated by 
the other two methods. As previously stated, the LRE method is not an suitable 
method for forensic DNA quantification when used in conjunction with TaqMan® 
chemistries. Further, the smaller spread in mixture ratios between the MRP and 
VC methods suggest the VC method can improve the qPCR reproducibility over 
extended periods. 
 
Conclusions	  
 This experiment examined three methods of quantifying DNA for samples 
that were run in quadruplicate over the course of 26 months. Those three 
methods were MRP, VC, and LRE. The MRP and VC calculations are based on 
the use of standards of known concentration to calculate the DNA concentration 
of an unknown, while LRE is a modeling-based method that does not require a 
standard curve to quantify the DNA. 	  
Currently, MRP is the standard method for quantification. There are 
however a few issues with this method. The first issue is reproducibility. Each 
time an assay is run, a new standard curve must be generated and 
simultaneously run with the questioned samples. This not only uses more time 
and reagents, but introduces the error associated with the procurement of the 
linear parameters. This work corroborates previous findings and shows the 
concentrations of the same samples run over a significant period of time does not 
remain the same. It also shows that there is variation both within and between 
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runs. This reproducibility problem can lead to issues during downstream PCR 
processing. Another issue is the cost; running sixteen standards on every plate 
takes up space that potentially could be used to run other samples. Using the 
MRP does allow for a control other than the IPC. It is possible to use the 
standard curve to judge the quality of a run; if the standard curve does not result 
in expected slopes and/or y-intercepts then there could have been an issue with 
the run. However, if the standards fail, it is impossible to determine the source of 
the error. That is, additional testing would be required to assess whether the 
failure was due to the reagents, instrument or the standards themselves. 
Using modeling software like LRE that bases the concentration on the 
fluorescence of the individual sample may be considered an alternative to the 
standard curve based methods. Further, it has the potential to decrease cost 
and, like the VC method, allows for more samples to be run on a single plate. 
The LRE software is a freeware, easy to use, and it integrates well with the 
current analysis software. However, the software, in its current form, is not ready 
to be used as the main means of DNA concentration determination in a forensic 
setting, especially if the lab utilizes a TaqMan® probe based assay like 
Quantifiler® Duo.  
Using a validated curve is a worthwhile alternative to determine DNA 
concentration. This method provides consistent results and shows less variation 
over time than both LRE and MRP. Furthermore, it is a cost effective method 
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since it allows for more samples to be run on an individual plate, and does not 
take any longer than the standard MRP method.  
For the validated curve to be used effectively, certain factors need to be 
taken into consideration. Since detection systems are expected to differ between 
instruments. Therefore, if a lab has more than one qPCR instrument, then each 
machine may require its own validated curve. Further, a different validated curve 
should also be made for the different assays being used. For example, a 
validated curve for Quantifiler Duo® will only work for that kit.  
This work also examined two possible causes of run variation, which are 
kit lot and calibration. While it appears that kit lot may cause some of the 
variation, data suggests that instrument calibration has the largest effect. The 
effect that calibration has seems to be larger for VC than the other methods. The 
variation is much smaller within a calibration than it was throughout all the runs 
combined. This leads to the conclusion that if a validated curve is going to be 
used, a new validated curve should be generated after each calibration in order 
to maintain the highest level of consistency and accuracy during DNA 
quantification.	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